- NCT00046267
Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients
Not ApplicableCompleted - NCT00046163
A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension
Phase 4Terminated - NCT00046215
Transcranial Magnetic Stimulation to Study Imagination of Movement
Completed - NCT00046085
Online Family Support and Education for Schizophrenia
Not ApplicableCompleted - NCT00046202
Study of Inborn Errors of Cholesterol Synthesis and Related Disorders
Completed - NCT00046189
Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
Completed - NCT00046111
A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors
Phase 1Completed - NCT00046124
Organophosphate Pesticides and Human Reproductive Health
Completed - NCT00046150
12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.
Phase 3Completed - NCT00046137
Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis
Phase 3Completed - NCT00046176
A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients
Phase 3Completed - NCT00046072
A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis
Phase 2Completed - NCT00045968
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Phase 3Unknown - NCT00046020
Study Evaluating Venlafaxine ER in Recurrent Depression
Phase 4Completed - NCT00045981
The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)
Phase 2Completed - NCT00045955
Long-Term Safety Performance of Fexofenadine in Asthma
Phase 3Completed - NCT00046033
Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance
Phase 2Completed - NCT00045994
The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling
Phase 2Completed - NCT00046059
Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)
Completed - NCT00045942
PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)
Phase 1Completed - NCT00045916
Optimizing Electroconvulsive Therapy for Depression
Phase 4Completed - NCT00044824
Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
Phase 3Completed - NCT00044811
Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
Phase 3Completed - NCT00045903
Cognitive Behavioral Therapy Plus Drug Treatment for Obsessive Compulsive Disorder
Not ApplicableCompleted - NCT00045877
Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
Phase 2Completed - NCT00045864
Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.
Phase 2Completed - NCT00045773
Treatment Outcome of Vascular Depression
Completed - NCT00045799
Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill
Phase 3Completed - NCT00045838
HIV-1 Vaccine Test in Uninfected Adult Volunteers
Phase 1Withdrawn - NCT00045812
SCH-58235 (Ezetimibe) to Treat Homozygous Sitosterolemia
Phase 2Completed - NCT00045786
Study to Determine the Safety and Preliminary Efficacy of CC-1088 in the Treatment of Myelodysplastic Syndromes
Phase 2Completed - NCT00044928
Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection
Phase 4Completed - NCT00045760
The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis
Phase 4Completed - NCT00044863
Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma
Phase 2Completed - NCT00044902
Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)
Phase 2Completed - NCT00044889
Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia
Phase 2Completed - NCT00044837
Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women
Phase 1Terminated - NCT00044915
Repinotan in Patients With Acute Ischemic Stroke
Phase 2Completed - NCT00044785
Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors
Phase 1Terminated - NCT00044759
Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma
Phase 3Completed - NCT00044733
Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant
Phase 2Completed - NCT00044720
Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients
Phase 4Completed - NCT00044876
Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist
Phase 2Completed - NCT00044772
Study Evaluating Venlafaxine ER in Patients With Panic Disorder
Phase 3Completed - NCT00044746
Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections
Phase 4Completed - NCT00044798
Magnetic Stimulation Therapy for Treating Vascular Depression
Phase 3Completed - NCT00044629
Combined Behavioral/Pharmacological Therapy for Insomnia
Phase 2Completed - NCT00044668
Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination
Phase 3Completed - NCT00044681
A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression
Phase 3Completed - NCT00044694
Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
Phase 2Completed - NCT00044707
Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide
Phase 2Completed - NCT00044590
Parkinson's Diseases Susceptibility Genes and Pesticides
Completed - NCT00044616
Relapse Prevention for Bipolar Type-II Disorder
Phase 4Completed - NCT00044655
Switching Medication to Treat Schizophrenia
Phase 4Completed - NCT00044603
Vulnerability of the Fetus/Infant to PAH, PM2.5 AND ETS.
Completed - NCT00044642
Lorazepam-Induced Toxicity in the Aged
Phase 4Completed - NCT00044564
Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell Carcinoma
Phase 2Completed - NCT00044538
Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients
Phase 2Completed - NCT00044473
A Study of the Effectiness and Safety of Levofloxacin in Treating Children With a Rapid and Severe Onset of Infection and Inflammation of the Middle Ear That is Difficult to Treat
Phase 3Completed - NCT00044486
Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)
Phase 3Completed - NCT00044512
A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma
Phase 2Completed - NCT00044551
Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma
Phase 2Completed - NCT00044525
Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients
Phase 2Completed - NCT00044577
New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects
Phase 3Completed - NCT00044395
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
Phase 3Completed - NCT00044408
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
Phase 3Completed - NCT00044421
Treatment of Peripheral Neuropathy in Patients With Diabetes
Phase 3Completed - NCT00044434
Bupropion as a Smoking Cessation Aid in Alcoholics
Phase 4Completed - NCT00044447
Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione
Phase 3Completed - NCT00044460
Efficacy and Safety In Poorly Controlled Type 2 Diabetics
Phase 4Completed - NCT00044382
Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome
Phase 2Completed - NCT00044356
Phase II Trial of Allovectin-7® for Metastatic Melanoma
Phase 2Completed - NCT00044369
Role of the Toxic Metal Cadmium in the Mechanism Producing Infertility With a Varicocele
Completed - NCT00044343
GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin
Phase 2Completed - NCT00044317
Health Effects of Particulate Acids in Late Adolescence
Completed - NCT00044291
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Phase 3Completed - NCT00044265
Treatment of Pediatric Hypertension With Altace Trial
Phase 4Completed - NCT00044304
Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome
Phase 2Active Not Recruiting - NCT00044278
Pediatric Epilepsy Study in Subjects 1-24 Months
Phase 2Completed - NCT00044187
The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder
Phase 4Completed - NCT00044239
Characterization of Childhood-Onset Obsessive-Compulsive Disorder
Completed - NCT00044252
Role of Hormones in Susceptibility to Seizures in Women With Epilepsy
Completed - NCT00044213
Trial to Assess Chelation Therapy (TACT)
Phase 3Completed - NCT00044226
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
Phase 2Unknown - NCT00044200
Positron Emission Tomography (PET) to Study Brain Signaling
Completed - NCT00044148
The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes
Phase 2Completed - NCT00044135
A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
Phase 2Unknown - NCT00044174
Dyadic Interactions in Depressed and Non-Depressed Mothers and Their Infants
Completed - NCT00044057
A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)
Phase 2Completed - NCT00044005
Safety and Tolerability Study of Drug to Treat Schizophrenia
Phase 2Completed - NCT00044018
CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma
Phase 2Completed - NCT00044031
Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma
Phase 3Completed - NCT00044070
A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients
Phase 2Completed - NCT00043329
Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis
Completed - NCT00044044
A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia
Phase 2Completed - NCT00044109
Magnets in the Treatment of Sciatica
Phase 2Completed - NCT00043888
Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR
Phase 3Completed - NCT00043992
Outdoor Allergen Exposure, Sensitivity, and Acute Asthma
Completed - NCT00043966
Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects
Phase 3Completed - NCT00043953
Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects
Phase 2Completed